June 30, 2020 / 1:55 AM / 4 days ago

BRIEF-Health Canada Allows COVID-19 Patients With Respiratory Failure To Be Given Nuvox Pharma's Oxygen Therapeutic In Phase Iia Clinical Trial

June 29 (Reuters) - Nuvox Pharma:

* HEALTH CANADA ALLOWS COVID-19 PATIENTS WITH RESPIRATORY FAILURE TO BE GIVEN NUVOX PHARMA’S OXYGEN THERAPEUTIC IN PHASE IIA CLINICAL TRIAL

* NUVOX PHARMA - RECEIVED “NO OBJECTION LETTER” FROM HEALTH CANADA TO PROCEED WITH PHASE IIA CLINICAL TRIAL OF NANO2 IN COVID-19 SUBJECTS WITH AHRF Source text for Eikon: ]

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below